Related Experiment Videos
Management of patent ductus arteriosus in preterm babies
Insights
Early indomethacin treatment for premature infants with respiratory distress syndrome and patent ductus arteriosus significantly reduced surgical ligations. This approach aims to minimize ventilation time and prevent bronchopulmonary dysplasia.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Respiratory Medicine
Background:
- Patent ductus arteriosus (PDA) frequently occurs in premature infants with respiratory distress syndrome (RDS).
- Delayed closure of PDA can lead to complications in vulnerable preterm neonates.
Purpose of the Study:
- To evaluate the effectiveness of indomethacin treatment for PDA in premature infants with RDS.
- To compare outcomes between surgical ligation and indomethacin therapy for PDA.
Main Methods:
- Retrospective analysis of 57 preterm infants diagnosed with PDA between 1975 and 1977.
- Comparison of treatment strategies: surgical ligation versus indomethacin therapy.
- Monitoring of early mortality and need for surgical intervention.
Main Results:
- In the first period, 11 of 23 infants with PDA underwent surgical ligation.
- In the second period, 18 of 34 infants received indomethacin, with only 3 requiring subsequent ligation.
- Indomethacin treatment was associated with a decreased need for surgical intervention.
Conclusions:
- Early indomethacin administration is now the preferred policy for PDA in premature infants with RDS.
- This strategy aims to reduce surgical procedures, mechanical ventilation duration, and the incidence of bronchopulmonary dysplasia.
Abstract:
There is a higher incidence of delayed closure of the patent ductus arteriosus in premature babies with respiratory distress syndrome. From July, 1975, to December, 1977, 57 small, preterm infants with patent ductus arteriosus were diagnosed at our neonatal intensive care unit. From July, 1975, until September, 1976 (first period), 23 patients were diagnosed, and 11 underwent surgical ligation of a patent ductus arteriosus. There were 3 early deaths. From October, 1976, until December, 1977, out of a total of 34 patients with diagnosed patent ductus, 18 were treated with indomethacin, and only 3 required ligation. Our present policy for patent ductus arteriosus with respiratory distress syndrome in the premature baby is to initiate early treatment with indomethacin. If this treatment fails and the infant's status deteriorates, we perform early surgical ligation of the ductus in order to minimize the time on mechanical ventilation and lessen the chances of the development of bronchopulmonary dysplasia.